Photoacoustic imaging of lacZ gene expression in vivo by Li, Li et al.
JBO LETTERS
Downloaded Photoacoustic imaging of
lacZ gene expression
in vivo
Li Li,a,† Roger J. Zemp,a,† Gina Lungu,b George Stoica,b
and Lihong V. Wanga,*
aWashington University in St. Louis, Optical Imaging
Laboratory, Department of Biomedical Engineering, St. Louis,
Missouri 63130
bTexas A&M University, Department of Pathobiology,
College Station, Texas 77840
Abstract. In the postgenomic era, imaging techniques are
playing an important role in visualizing gene expression in
vivo. This work represents the first demonstration of pho-
toacoustic tomography PAT for reporter gene imaging.
Rats inoculated with 9L/lacZ gliosarcoma tumor cells are
imaged with PAT before and after injection of X-gal, a
colorimetric assay for the lacZ-encoded enzyme
-galactosidase. Using far-red optical illumination, the ge-
netically tagged tumors in rats are clearly visualized by
PAT following the assay. The spatial resolution is quanti-
fied to be less than 400 m, while 500-nM-level sensitiv-
ity is demonstrated. With the future development of new
absorption-based reporter gene systems, it is anticipated
that photoacoustic technology will provide a valuable tool
for molecular imaging research. © 2007 Society of Photo-Optical
Instrumentation Engineers. DOI: 10.1117/1.2717531
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Molecular imaging techniques are now being developed to
visualize biochemistry and function to complement anatomi-
cal imaging techniques. In gene expression imaging, an exog-
enous “reporter gene” is usually incorporated into the genome
of cell lines or the animal model of interest in such a way that
its expression is under the control of some desired promoter
or enhancer. By using a ubiquitously strong promoter, cells
can be genetically tagged for in-vivo tracking. The expression
products of reporter genes provide required contrast for an
imaging modality either directly or indirectly via some assay.
Because many diseases involve genetic disorders, either in-
herited or originating from environmental stress, visualization
of gene expression may significantly impact the future of
medicine.
Many widely used medical imaging modalities, such as
positron emission tomography PET, single photon emission
tomography SPECT, and magnetic resonance imaging
MRI, have been used to image gene expression in vivo.1
Recently, optical methods are attracting increasing interest be-
cause of various optical contrast mechanisms, minimized
background noise, high sensitivity, use of nonionizing radia-
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microscopy offers micron-scale resolution, the applicability is
primarily limited to submillimeter imaging depths in the der-
mis, where photon transportation is sufficiently ballistic. Pla-
nar fluorescence imaging technology using reporter genes
such as green fluorescent protein enables whole body imaging
of small animals, although at low spatial resolution due to
multiple scattering of light. Bioluminescence imaging using
the luciferase has seen great success in molecular imaging. It
eliminates the problem of endogenous fluorescence encoun-
tered in planar fluorescence imaging; however, again it suffers
from low spatial resolution of deep structures. Fluorescence
tomography is emerging as a powerful molecular imaging
tool,3 with submillimeter spatial resolution possible;4 how-
ever, the reconstruction procedures are also highly ill posed
and dependent on optical diffusion theory, which breaks down
within a few transport-mean-free paths, often a dimension of
interest for small animals.
In this work, as well as our conference report,5 we demon-
strate, for the first time to our knowledge, photoacoustic im-
aging as a promising candidate for imaging gene expression
in vivo by exploiting a new contrast mechanism—optical ab-
sorption. Photoacoustic waves are generated by inducing
thermo-elastic expansion in optically absorbing structures ir-
radiated by pulsed laser light. In photoacoustic tomography
PAT, the photoacoustic waves are detected with ultrasonic
transducers at various positions surrounding the object. The
absorbing structures are then mapped into the image space
through reconstruction. Image contrast in PAT is due to opti-
cal absorption, yet spatial resolution is based on ultrasonic
detection and is not limited by optical scattering or recon-
struction regularization. Photoacoustic spatial resolution can
approach the ultrasonic diffraction limit, which is a fraction of
a millimeter for diagnostic-frequency ultrasound. This resolu-
tion has been demonstrated up to several centimeters in
tissue-mimicking phantoms.6–8 PAT has seen great success in
small animal imaging during its short history.9,10 In this work,
we demonstrate 400-m spatial resolution subdermal photoa-
coustic imaging of gene expression, a resolution scale finer
than the state-of-the-art fluorescence tomography.4 While ul-
trasonic transducer bandwidth may be scaled to obtain even
higher resolutions, the key emphasis in this work is to dem-
onstrate the feasibility of using photoacoustic technology to
visualize optical absorption as a new contrast mechanism for
subdermal gene expression imaging.
We chose to image the expression of lacZ, one of the most
widely used reporter genes. The lacZ gene encodes
-galactosidase, an E. coli enzyme responsible for lactose
metabolism. We used the sensitive chromogenic assay
5-bromo-4-chloro-3-indolyl--D-galactoside X-gal, an opti-
cally transparent lactose-like substrate, which yields a stable
dark blue product following the cleavage of the glycosidic
linkage by -galactosidase. We demonstrate that PAT is sen-
sitive to the increase in optical absorption due to this assay.
Few other methods for imaging lacZ expression have been
reported. One MRI approach used a -galactosidase-cleavable
paramagnetic contrast agent, which was introduced into a Xe-
nopus embryo at the two-cell stage.11 Recently, planar fluo-
rescence imaging was used to image the fluorescent prod-1083-3668/2007/122/020504/3/$25.00 © 2007 SPIE
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-D-galactopyranoside DDAOG cleaved by -galacto-
sidase.12
We first measured the molar extinction spectrum of the
blue product to determine an appropriate illumination wave-
length. Concentrated -galactosidase solution was obtained
from the lysate of 9L/lacZ cells and then divided equally into
five cuvettes. 20 l of X-gal solutions with different concen-
trations were added to the first four cuvettes, while 20 l of
water was added to the last cuvette as a baseline. After given
enough time for the reaction, these solutions were measured
for the absorbance using a spectrometer USB2000, Ocean
Optics, Dunedin, FL. Assuming all the X-gal molecules were
cleaved, we calculated the concentrations of the blue product.
The assumption was verified by observing that the absorbance
and concentration of the blue product at every single wave-
length followed a linear relationship Fig. 1a. Molar extinc-
tion coefficients were obtained from the slope of Fig. 1a. In
Fig. 1b, we compared the molar extinction spectrum of the
blue product with those of the main biological absorbers: oxy-
hemoglobin HbO2 and deoxyhemoglobin Hb. We chose
far-red light at 650 nm, where the contrast between the ab-
sorption of the blue product over the background absorption
from hemoglobin is high. Illumination at this wavelength can
penetrate deeply into tissue.
A diagram of our PAT system is shown in Fig. 2a. A dye
laser pumped by a Q-switched Nd:YAG laser, emitted light
at 650 nm. Before reaching the animal, the light was broad-
ened by a concave lens and a ground glass. The illumination
was measured to be 5 mJ/cm2 near the skin. An ultrasonic
Fig. 1 a Linear fitting of absorbance versus concentration of the blue
product at 650 nm. b Comparison of absorption spectra for the blue
product, HbO2, and Hb.transducer with a center frequency of 2.25 MHz was me-
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amplified, digitized, and averaged at each scan position. Sig-
nals from a photodiode were used to compensate for fluctua-
tions in the illuminating energy. Images were reconstructed
using a modified back-projection algorithm.
Approximately 5 million 9L/lacZ gliosarcoma tumor cells
American Type Culture Collection, Manassas, VA were in-
oculated subcutaneously under the scalps of Sprague-Dawley
rats. The tumors were left to grow until a small bump was
present. Hair was removed before imaging. Animals were
kept under anesthesia and their blood oxygenation and heart
rates were monitored during experiments. 25 l of X-gal so-
lution 20 mg/ml, Fermentas, Hanover, MD was injected
subcutaneously near the tumor. The same amount of X-gal
was injected in a nontumor location in the symmetric position
on the contralateral side as a control. Two separate PAT im-
ages were taken before and after injection.
Figure 3a shows the PAT image prior to X-gal injection.
While the median fissure and some cortical vessels are visible,
the tumor is not. X-gal was injected at points indicated by
arrows in Fig. 3c. Following the assay, the tumor is clearly
seen in Fig. 3b. No signal up-regulation was observed at the
right-side injection point, which served as a negative control.
Figure 3c shows the photograph of the rat head following
X-gal injection and just prior to imaging. Although a small
bump is present, the exact shape of the tumor and distribution
of lacZ expression was unknown. Figure 3d shows the un-
derside of the dissected scalp in the rectangular region indi-
cated in Fig. 3c, showing the X-gal stained tumor, which is
Fig. 2 PAT setup and experiments quantifying the system’s perfor-
mance. a Schematic of PAT system setup. b PAT image of two
crossed hairs embedded in gelatin. The inset shows a 1-D profile of
the dashed line, where two hairs are separated by 400 m. c PAT
image of a tube of 5.4-M blue product embedded 5 mm deep in
chicken tissue.dark blue in color.
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crossed-hair phantom, shown in Fig. 2b. The two hairs be-
come clearly distinct at the 400-m separation, which means
the resolution of our system is less than this. To estimate the
molar sensitivity, we imaged a 250-m inner diameter tube,
transparent to light and ultrasound, filled with a solution of
blue product at a concentration of 5.4 M and embedded
5 mm deep in chicken tissue Fig. 2c. The region with blue
product was estimated to be 3.1 times stronger than the back-
ground with a contrast-to-noise ratio CNR of 10.5. Hence,
the minimum detectable concentration of blue product with
CNR1 was less than 515 nM. Compared with other sub-
dermal imaging technologies with submillimeter resolution,
this technique has a minimum detectable concentration less
than the submillimolar levels typically required in MRI,1 but
higher than the 100 fM levels possible with fluorescence
tomography.4
Note that the lacZ reporter gene also possesses an intrinsic
signal-amplification mechanism. As an enzyme, a single
-galactosidase molecule can cleave multiple X-gal mol-
ecules to produce a large number of blue product molecules.
Hence our calculated minimum detectable concentration per-
tains to the blue product, while the actual levels of
-galactosidase, the real expression product, may be signifi-
cantly lower. Multiwavelength techniques can be applied to
push this limit of sensitivity even further by exploiting the
spectral information to recognize specific absorbers from the
background.
It took us 25 min to acquire one frame, due to the slow
10-Hz pulse repetition rate PRF of the laser and the time-
Fig. 3 Results from photoacoustic tomography at 650 nm. a and b
Photoacoustic images before and after the injection of X-gal. c Pho-
tograph of the rat’s head prior to second scan. The two arrows indicate
the position of injection of X-gal. d Photograph of the underside of
the rat’s scalp in the rectangular region in c, excised after sacrificing
the animal. The line scale represents 5 mm.consuming mechanical scanning of the single-element ultra-
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PRF lasers and ultrasonic phased arrays.
There are some limitations for in-vivo applications of
X-gal. It can cause skin irritation occasionally, and the in-vivo
dynamics of the reaction is poorly understood. Systemic de-
livery through the tail vein seems inefficient in our animal
model. Given the enormous number of pigments existing in
nature, however, future development of absorption-based re-
porter gene systems may provide new approaches for PAT of
gene expression in vivo. An ideal reporter gene system should
have a simple reaction mechanism with minimized require-
ments for delivery, and should generate highly absorbing
products in the near-infrared region of the optical spectrum.
In summary, we demonstrate the feasibility of imaging
gene expression by photoacoustic tomography for the first
time. The concept of using reporter genes that modulate opti-
cal absorption as an image contrast mechanism represents a
new paradigm for gene expression imaging. We believe that
the development of new absorption-based reporter gene sys-
tems may provide new opportunities in molecular imaging
and basic science research.
Acknowledgment
We are grateful to Sergio Similache and Ovidiu Craciun for
assistance with animal handling. This research is funded in
part by the NIH grants R01 NS46214 BRP and R01
EB000712.
References
1. T. F. Massoud and S. S. Gambhir, “Molecular imaging in living sub-
jects: seeing fundamental biological processes in a new light,” Genes
Dev. 17, 545–580 2003.
2. R. Weissleder and V. Ntziachristos, “Shedding light onto live molecu-
lar targets,” Nat. Med. 9, 123–128 2003.
3. V. Ntziachristos, C. Tung, C. Bremer, and R. Weissleder, “Fluores-
cence molecular tomography resolves protease activity in vivo,” Nat.
Med. 8, 757–761 2002.
4. E. E. Graves, J. Ripoll, R. Weissleder, and V. Ntziachristos, “A sub-
millimeter resolution fluorescence molecular imaging system for
small animal imaging,” Med. Phys. 30, 901–911 2003.
5. L. Li, R. J. Zemp, G. Lungu, G. Stoica, and L. H. Wang, “Imaging of
gene expression in vivo with photoacoustic tomography,” Proc. SPIE
6086, 608608 2006.
6. C. G. A. Hoelen, F. F. M. de Mul, R. Pongers, and A. Dekker, “Three-
dimensional photoacoustic imaging of blood vessels in tissue,” Opt.
Lett. 23, 648–650 1998.
7. R. O. Esenaliev, A. A. Karabutov, and A. A. Oraevsky, “Sensitivity
of laser opto-acoustic imaging in detection of small deeply embedded
tumors,” IEEE J. Sel. Top. Quantum Electron. 5, 981–988 1999.
8. G. Ku and L. V. Wang, “Deeply penetrating photoacoustic tomogra-
phy in biological tissues enhanced with an optical contrast agent,”
Opt. Lett. 30, 507–509 2005.
9. X. Wang, Y. Pang, G. Ku, X. Xie, G. Stoica, and L. V. Wang, “Non-
invasive laser-induced photoacoustic tomography for structural and
functional imaging of the brain in vivo,” Nat. Biotechnol. 21, 803–
806 2003.
10. R. A. Kruger, W. L. Kiser, D. R. Reinecke, G. A. Kruger, and K. D.
Miller, “Thermoacoustic optical molecular imaging of small ani-
mals,” Mol. Imaging 2, 113–123 2003.
11. A. Y. Louie, M. M. Huber, and E. T. Ahrens, “In vivo visualization of
gene expression using magnetic resonance imaging,” Nat. Biotechnol.
18, 321–325 2000.
12. C. Tung, Q. Zeng, K. Shah, D. E. Kim, D. Schellingerhout, and R.
Weissleder, “In vivo imaging of -galactosidase activity using far red
fluorescent switch,” Cancer Res. 64, 1579–1583 2004.
March/April 2007  Vol. 1223
Use: http://spiedigitallibrary.org/ss/TermsOfUse.aspx
